STRATEC SE

Declaration of Voting Results & Voting Rights Announcements • Oct 31, 2012

News Details

Voting Rights Announcements | 31 October 2012 20:12

STRATEC Biomedical AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

STRATEC Biomedical AG

31.10.2012 20:12

Dissemination of a Voting Rights Announcement, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

---

1. Voting Rights Announcement
   Tanja van Dinter, Germany, notified us on October 30, 2012 pursuant to § 21
   (1) of the German Securities Trading Act (WpHG) that her share of the
   voting rights in STRATEC Biomedical AG, Birkenfeld, Germany, ISIN:
   DE0007289001, exceeded the threshold of 10% on October 24, 2012 and
   amounted to 10.38% on this date (1,217,953 voting rights).

2. Voting Rights Announcement
   Bettina Siegle, Germany, notified us on October 30, 2012 pursuant to § 21
   (1) of the German Securities Trading Act (WpHG) that her share of the
   voting rights in STRATEC Biomedical AG, Birkenfeld, Germany, ISIN:
   DE0007289001, exceeded the threshold of 10% on October 24, 2012 and
   amounted to 10.53% on this date (1,235,620 voting rights).

3. Voting Rights Announcement
   Hermann Leistner, Germany, notified us on October 30, 2012 pursuant to § 21
   (1) of the German Securities Trading Act (WpHG) that his share of the
   voting rights in STRATEC Biomedical AG, Birkenfeld, Germany, ISIN:
   DE0007289001, fell below the threshold of 15% on October 24, 2012 and
   amounted to 10.14% at this date (1,190,456 voting rights).
   Of these, 9.71% (1,140,000 voting rights) were attributable to him pursuant
   to § 22 (1) Sentence 1 No. 1 of the German Securities Trading Act (WpHG)
   via two companies he controls, namely Herdor GmbH & Co. KG,
   Unterschleißheim, Germany, and Herdor Beteiligungs GmbH, Unterschleißheim,
   Germany.

4. Voting Rights Announcement
   Ralf Leistner, Germany, notified us on October 30, 2012 pursuant to § 21
   (1) of the German Securities Trading Act (WpHG) that his share of the
   voting rights in STRATEC Biomedical AG, Birkenfeld, Germany, ISIN:
   DE0007289001, exceeded the threshold of 10% on October 24, 2012 and
   amounted to 10.57% on this date (1,241,010 voting rights).

31.10.2012 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---

Language: English
Company: STRATEC Biomedical AG
Gewerbestr. 37
75217 Birkenfeld
Germany
Internet: www.stratec.com

End of Announcement DGAP News-Service

---